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Bipolar disorder (BD) is a severe and highly heritable neuropsychiatric disorder with a lifetime prevalence of 1%. Molecular genetic
studies have identiﬁed the ﬁrst BD susceptibility genes. However, the disease pathways remain largely unknown. Accumulating
evidence suggests that microRNAs, a class of small noncoding RNAs, contribute to basic mechanisms underlying brain
development and plasticity, suggesting their possible involvement in the pathogenesis of several psychiatric disorders, including
BD. In the present study, gene-based analyses were performed for all known autosomal microRNAs using the largest genome-wide
association data set of BD to date (9747 patients and 14 278 controls). Associated and brain-expressed microRNAs were then
investigated in target gene and pathway analyses. Functional analyses of miR-499 and miR-708 were performed in rat hippocampal
neurons. Ninety-eight of the six hundred nine investigated microRNAs showed nominally signiﬁcant P-values, suggesting that BD-
associated microRNAs might be enriched within known microRNA loci. After correction for multiple testing, nine microRNAs
showed a signiﬁcant association with BD. The most promising were miR-499, miR-708 and miR-1908. Target gene and pathway
analyses revealed 18 signiﬁcant canonical pathways, including brain development and neuron projection. For miR-499, four
Bonferroni-corrected signiﬁcant target genes were identiﬁed, including the genome-wide risk gene for psychiatric disorder CACNB2.
First results of functional analyses in rat hippocampal neurons neither revealed nor excluded a major contribution of miR-499 or
miR-708 to dendritic spine morphogenesis. The present results suggest that research is warranted to elucidate the precise
involvement of microRNAs and their downstream pathways in BD.
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INTRODUCTION
Bipolar disorder (BD) is a severe neuropsychiatric disorder with an
estimated lifetime prevalence of 1%.1 BD is characterized by
recurrent episodes of mania and depression, and shows a herita-
bility of ~ 70%.2 Molecular genetic candidate studies and—more
recently—genome-wide association studies (GWAS) have identi-
ﬁed the ﬁrst BD susceptibility genes.3–7 However, the disease
pathways and underlying regulatory networks remain largely
unknown.8
Accumulating evidence suggests that microRNAs (miRNAs) are
implicated in the biological pathways that regulate brain devel-
opment and synaptic plasticity.9,10 This in turn suggests their
possible involvement in the pathogenesis of several psychiatric
disorders,11,12 including BD.13,14 Studies of the post-mortem brain
tissue of BD patients have demonstrated altered miRNA expres-
sion proﬁles in the prefrontal cortex.13,14
The miRNAs are a class of 21–25-nucleotide small noncoding
RNAs. In the nucleus they are transcribed by RNA polymerase II to
primary miRNA (pri-miRNA) transcripts, which are double-stranded
stem loop structures comprising 100–1000 nucleotides.15,16
Approximately 50% of all vertebrate miRNAs are processed from
the introns of protein-coding genes or from genes encoding other
noncoding RNA classes. However, miRNAs can also be encoded in
intergenic regions.17
The pri-miRNAs are then processed by the Drosha-DGCR8
complex to precursor miRNAs.18,19 These precursor miRNAs are
60–70 nucleotides in length. The precursor miRNAs are exported
to the cytoplasm, where they are cleaved into ∼ 20-base pair (bp)
mature miRNAs by the Dicer enzyme.16,20 The mature miRNAs are
incorporated into the RNA-induced silencing complex, which then
targets distinct sets of messenger RNAs (mRNAs).21
The miRNAs control the expression of their target genes by
binding to target sites within the mRNAs, typically in their 3′
untranslated regions.22,23 A region of 2–7 or 2–8 consecutive
nucleotides from the 5′ end of the mature miRNA forms the seed
region, which is crucial for the recognition of the target genes.24 In
general, each miRNA controls up to several hundred target
mRNAs, whereas one mRNA target can be subjected to synergistic
regulation by multiple miRNAs.25,26 In consequence, miRNAs
integrate different intracellular signals and regulate a number of
signaling pathways.27,28 Interestingly, the miRNA regulatory effect
itself has been shown to be a heritable trait in humans.29
The hypothesis that miRNAs are implicated in BD is also
supported by the results of the largest GWAS of BD to date.6 In
this study, a single-nucleotide polymorphism (SNP) in an
intergenic region ﬂanking MIR2113 on chromosome 6q16.1 was
the eighth strongest ﬁnding. However, no signiﬁcant enrichment
of BD-associated genes within the known or predicted targets of
MIR2113 was observed.6
Several studies have investigated the role of single miRNAs in
the development of psychiatric disorder,30–32 including BD.33
However, to our knowledge, no systematic, genome-wide analysis
of miRNA-coding genes has yet been performed. The aim of the
present study was, thus, to determine whether common variants
at any of the known miRNA loci contribute to the devel-
opment of BD.
MATERIALS AND METHODS
Sample description
The gene-based tests were performed using data from our previous GWAS
of BD (9747 patients and 14 278 controls).6 This GWAS data set combined
data from Canada, Australia and four European countries (MooDS) with the
GWAS results of the multinational Psychiatric Genomics Consortium
(PGC).3 The study was approved by the respective local Ethics Committees.
Written informed consent was obtained from all participants.6
Genome-wide miRNA association analysis
For the gene-based analyses, a set-based testing approach adapted from
the versatile gene-based test for GWAS34 was used. This algorithm is
obtainable upon request. The chromosomal positions of all miRNAs
(n=718) were obtained from miRBase release 13.0.35 This release contains
a high conﬁdence set of miRNAs for which detailed information about
miRNA function and predicted target genes is available. Using the
summary statistics, gene-wide P-values were calculated for all 636
autosomal miRNAs and their ± 20 kilobase (kb) ﬂanking sequences.
Twenty-seven of these miRNA loci contained no common SNP. Therefore,
gene-wide P-values were obtained for 609 miRNAs.
The applied statistical algorithm is described in more detail in the article
by Liu et al.34 Brieﬂy, SNPs within these boundaries were grouped together,
and a set-based test statistic was calculated as the sum of the χ2 one
degree of freedom association P-values within the miRNA. The test statistic
was compared with simulated test statistics from the multivariate normal
distribution. An empirical miRNA-based P-value was calculated as the
proportion of simulated test statistics above the observed test statistic. For
the purposes of the present study, the 10% most signiﬁcant SNPs for each
miRNA were summarized. The calculated gene-based P-values were
Bonferroni-corrected for multiple testing according to the number of
investigated miRNAs (n=609).
As different reference panels were used for the imputation of the
MooDS and PGC genotype data (1000 Genomes Project, February 2012
release, and HapMap phase 2 CEU, respectively), we used simulated test
statistics on the basis of an intermarker linkage disequilibrium (LD)
structure as derived from the HapMap phase 2 population genotypes.
However, for miRNAs that showed a signiﬁcant association with BD after
Bonferroni correction, we also calculated gene-based tests based on 1000
Genomes Project phase 3 population genotypes.
Inﬂation of the observed and expected P-values for different SNP
subcategories (SNPs in miRNA loci, SNPs in genes and intergenic SNPs) was
deﬁned as the degree of deviation from the expected uniform distribution
in the quantile–quantile (Q–Q) plot and tested for signiﬁcance using
Fisher’s exact test (one-sided) for different P-value thresholds. Only LD-
pruned SNPs (r2o0.8) were used for the enrichment analysis.
Follow-up of miRNA association results—regional association plots
A window-based approach that included common variants in miRNAs and
ﬂanking sequences was applied. To determine whether the signal was
associated with any of the miRNAs of interest, visual inspection of the
regional association plots was performed.
Regional association results from our BD GWAS6 were plotted for all
associated miRNAs and their ± 500-kb ﬂanking regions using LocusZoom.36
A signal was considered miRNA-associated if the top SNP of the region was
located at, or was in high or moderate LD (r240.6) with, the miRNA locus.
Follow-up of miRNA association results—miRNA brain expression
To investigate expression of the associated miRNAs in the human brain,
data from a recent study of miRNA expression patterns in the developing
human brain were re-analyzed.37 A miRNA was deﬁned as showing brain
expression if it had a total read count of 4120 across all investigated
samples.37
In addition, miRNA expression was measured in rat cortical neurons and
forebrain. All procedures involving animals followed the guidelines of the
German Animal Protection Legislation and the experiments were approved
by the Local Committee for Animal Health (RP Gießen). Total RNA was
isolated from the postnatal day 15 rat forebrain or synaptosomes, as
described elsewhere.38 Brieﬂy, the total RNA from the forebrain of
postnatal day-15 Sprague–Dawley rat pups was extracted using peqGOLD
TriFast reagent (Peqlab, Erlangen, Germany) in accordance with the
manufacturer’s instructions. Small RNA libraries were constructed and
sequenced at the EMBL genomic core facility (Heidelberg, Germany) using
the HiSeq platform (Illumina, San Diego, CA, USA). The web-based software
MiRanalyzer was used to determine miRNA expression levels (http://
bioinfo2.ugr.es/miRanalyzer/miRanalyzer.php.).39
miRNA target gene analysis
Targets of the associated miRNAs 499, 708 and 1908 were obtained from
TargetScan (Release 6.2).40 The Allen human brain atlas (http://www.brain-
map.org/)41 was consulted to determine whether predicted target genes
are expressed in the human brain. Target genes were considered brain-
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expressed if they had shown expression in the hippocampal formation in
at least four of the six donor brains. Gene-based P-values for all brain-
expressed miRNA targets were calculated using versatile gene-based test
for GWAS,34 and our BD GWAS data set.6 To capture regulatory regions, the
default settings in versatile gene-based test for GWAS were used.
Enrichment of associated targets was calculated as follows: the number
of associated target genes for each miRNA was compared with the number
of associated genes from 100 000 random target sets of brain-expressed
genes. Each target gene set comprised the same number of genes as the
miRNA target genes itself.
Pathway analysis of target genes
The subsequent analyses were restricted to brain-expressed target genes
of miR-499, miR-708 and miR-1908, with a gene-based association P-value
of o0.05. If the chromosomal distance between two target genes was
below 100 kb or if the top SNPs of two target genes were in strong or
moderate LD (D’40.4), only the target gene with the lowest gene-based
P-value was retained in the pathway analysis to ensure the independency
of association signals. In total, 107 target genes were included in the
pathway analyses (Supplementary Box 1). Gene ontology (GO) and Kyoto
Encyclopaedia of Genes and Genomes pathway testing was performed
using the WebGestalt (Web-based Gene Set Analysis Toolkit) for the brain-
expressed, BD-associated target genes of the three associated miRNAs.
Bonferroni correction was used to adjust for multiple testings. Signiﬁcant
pathways were ﬁltered to achieve a minimum of three genes per set.
Functional analyses of miR-499 and miR-708 in rat hippocampal
neurons
To test the possible involvement of miR-499 or miR-708 in the regulation of
synaptic function, experiments were performed to investigate the effect of
miR-499 and miR-708 overexpression on dendritic spine morphogenesis in
primary rat hippocampal neurons. We initially focused on overexpression,
as this can be easily achieved by the transfection of expression plasmids
containing pri-miRNA cassettes. miRNA overexpression constructs were
generated by inserting the respective pri-miRNA sequences into the
3’-untranslated repeat of the luciferase reporter gene within pmiRGLO
(Promega, Madison, WI, USA). Thereby, luciferase reporter assays could be
used to monitor the efﬁciency of pri-miRNA processing. To investigate the
potential involvement of miR-499-5p and miR-708-5p in dendritic spine
morphogenesis, hippocampal neurons of embryonic day-18 Sprague–
Dawley rats (Charles River Laboratories, Sulzfeld, Germany) were trans-
fected with miRNA-overexpressing constructs for 6 days before ﬁxation.
Images with a resolution of 1024× 1024 pixels were obtained using a LSM5
Zeiss Pascal confocal microscope (Jena, Germany) and in a magniﬁcation
of × 63 /1.4. A maximum projection was reconstructed with the Zeiss LSM
510 Meta software from a z-stack consisting of seven optical slices at
0.45-μm interval. The average intensity of an area of 2180 nm2 containing
250–300 spines per cell was measured using the ImageJ 1.48v software
(National Institutes of Health, Bethesda, MD, USA), as described
elsewhere.38 During imaging and analysis, the investigator was blind to
the transfection condition.
RESULTS
Overall, the nominal P-values of SNPs at miRNA loci were enriched
with lower values than would be expected with a uniform P-value
distribution (Figure 1). This deviation from the expected normal
Q–Q plot distribution indicates a general enrichment for miRNAs
among BD-associated SNPs. Category testing for different P-value
thresholds revealed a signiﬁcant enrichment for BD-associated
SNPs in miRNA loci for P-valueso1 × 10− 4 (Supplementary
Table 1). This deviation was also observed among SNPs in genes
but not for intergenic SNPs.
Gene-based analysis in our BD GWAS data6 generated
nominally signiﬁcant P-values for 98 of the 609 miRNAs. These
included miR-2113, which was located at the genome-wide
signiﬁcant locus on chromosome 6q16.1 in the original BD GWAS
analyses.6 After correction for multiple testing, nine miRNAs
Figure 1. Quantile–quantile (Q–Q) plot of single-nucleotide poly-
morphism (SNP) P-values. The − log10 of the observed genome-
wide association studies (GWAS) P-values for linkage disequilibrium
(LD)-pruned SNPs (on the y axis) are plotted versus the − log 10 of
the expected P-values (under null, on the x axis). The solid line
represents expected uniform distribution. Red dots represent the
data distribution of P-values of SNPs at microRNA loci; blue dots
represent SNPs in genes; black dots represent P-values of intergenic
SNPs; and green dots represent the data distribution of all SNPs.
Table 1. Results of the gene-based tests for the nine microRNAs that withstood Bonferroni correction
miRNA Chr nSNPs Top SNP p Top SNP p Corr Gene miRNA-assoc. signal Expr. hum. brain
miR-499 20 27 rs3818253 6.58 × 10− 7 0.0012 Yes Yes
miR-640 19 21 rs2965184 7.23 × 10− 7 0.0012 Yes No
miR-708 11 72 rs7108878 3.45 × 10− 7 0.0012 Yes Yes
miR-581 5 36 rs697112 3.61 × 10− 6 0.0073 Yes No
miR-644 20 12 rs7269526 1.22 × 10− 5 0.0104 No No
miR-135a-1 3 20 rs9311474 2.16 × 10− 5 0.0122 No Yes
let-7 g 3 9 rs6445358 2.23 × 10− 5 0.0305 No Yes
miR-1908 11 16 rs174575 2.85 × 10− 5 0.0353 Yes Yes
miR-611 11 23 rs174535 5.03 × 10− 5 0.0457 No No
Abbreviations: Chr, chromosome; expr. hum. brain, expression in the human brain according to Ziats and Rennert;37 miRNA, microRNA; miRNA-assoc. signal,
speciﬁcity of the associated ﬁnding in the regional association plot; p Corr Gene, Bonferroni-corrected gene-based P-value; p Top SNP, P-value of the Top SNP
within gene; nSNPs, number of investigated SNPs; SNP, single-nucleotide polymorphism.
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showed a signiﬁcant association with BD (Table 1). The additional
calculation of gene-based tests for these nine miRNAs on the basis
of 1000 Genomes LD structure generated nominal P-values of
⩽ 7.20 × 10− 5 (Supplementary Table 2).
Visual inspection of the regional association plots revealed a
miRNA-associated signal for ﬁve of the nine miRNAs (Figure 2,
Supplementary Figures 1–4).
The re-analysis of the expression data from Ziats and Rennert37
revealed that ﬁve of the nine miRNAs were expressed in the
human brain (Table 1).
Three of these (miR-499, miR-708 and miR-135a-1) were also
found to be expressed in the rat forebrain. This method could not
be used to investigate the expression of the other miRNAs, as they
are not expressed in rats.35
The regional association plots and the miRNA expression data in
human brain tissue suggest that the three brain-expressed
miRNAs, that is, miR-499, miR-708 and miR-1908, are the most
promising candidates for further analyses. The three miRNAs had
296, 181 and 67 target genes, respectively. Of these 286, 174 and
56 showed brain expression (Table 2).
The target gene enrichment analysis showed no signiﬁcant
enrichment of BD-associated genes within the targets of miR-499,
miR-708 or miR-1908 (Table 2). After Bonferroni correction,
miR-1908 had one (KLC2) and miR-708 had two signiﬁcant target
genes (NRAS and CREB1), whereas miR-499 had four signiﬁcant
target genes (GPC6, C16orf72, WDR82 and CACNB2).
Pathway testing revealed 18 signiﬁcant canonical pathways that
are driven by brain-expressed target genes of the three miRNAs
(Table 2). For each miRNA, the results of the GO analysis are
presented as directed acyclic graphs (Supplementary Figure 5).
The target genes that drive a particular pathway are listed in
Supplementary Table 3.
Luciferase assays revealed efﬁcient processing of pri-miR-499,
but not pri-miR-708, upon transfection of the respective constructs
in neurons (Supplementary Figure 6). Overexpression of miR-499
led to a small and statistically nonsigniﬁcant increase in spine
volume (Figure 3), but no effect on spine density was observed. As
expected, transfection of the non-effective miR-708 expression
construct had no signiﬁcant effect on spine morphological
parameters. Taken together, these results suggest that increasing
levels of the BD-associated miR-499 have no—or only minimal—
modulatory function during dendritic spine morphogenesis.
DISCUSSION
The present genetic association results for miRNA-coding genes
suggest that miRNAs and their target genes may be implicated in
the development of BD. The nominal P-values of SNPs at miRNA
loci showed early deviation from the expected null line in the Q–Q
plot, and this leftward shift reﬂects an enrichment of BD-
associated SNPs at miRNA loci.
For the nine miRNAs that withstood Bonferroni correction, we
additionally calculated the gene-based tests on the basis of the
1000 Genomes LD structure. This analysis revealed nominally
gene-based P-values ⩽ 7.20 × 10− 5 for all nine miRNAs, indicating
that the results of gene-based tests on the basis of either HapMap
phase 2 or 1000 Genomes Project data are highly comparable
using our BD GWAS data.
Eight of the nine associated miRNAs were located in a host
gene, including the three brain-expressed miRNAs miR-499,
miR-708 and miR-1908. Recent studies have reported a high
correlation between the expression of a host gene and the
resident miRNA.15,42 Previous authors have hypothesized that this
ﬁnding may be because of the fact that miRNAs residing in introns
are likely to share their regulatory elements and primary transcript
with their host gene.24 Some authors point out that host genes
and their resident miRNAs may even have synergistic effects,
which would have important implications for the ﬁne-tuning of
gene expression patterns in the genome.43,44 On the basis of the
present genetic association results, it is impossible to determine
whether the association was attributable to the host gene, the
miRNA or both. Further analyses are therefore warranted to clarify
this, which was beyond the scope of the present analysis.
However, the general enrichment of BD-associated SNPs at miRNA
loci (Figure 1) and the results of our target gene analyses support
the hypothesis that the majority of the associated miRNAs are
implicated in BD etiology.
Regional association plots and expression data suggest that the
miRNAs miR-499, miR-708 and miR-1908 are the most promising
candidates in terms of the development of BD.
The miRNA miR-499 is located in a region on chromosome
20q11 that showed genome-wide signiﬁcant association in a
previous GWAS of BD.45 As miR-499 is located in a region of high
LD, which includes the genes GSS, MYH7B and TRPC4AP (Figure 2),
further analyses of this chromosomal region are required to reﬁne
the association signal.45 However, miR-499 represents a very
promising candidate in this region.
MiR-499 regulates apoptotic pathways involving the calcium-
dependent protein phosphatase calcineurin.46 A recent study
demonstrated an upregulation of miR-499 in the prefrontal cortex
of patients with depression.47 In a study of exosomal miRNA
expression, miR-499 showed differential expression in the post-
mortem brains of BD patients compared with controls.48 When
considering a possible pathomechanism, it is important to note
that a common SNP (rs3746444) is located in the seed region of
the mature miR-499-3p.49 This seed region is crucial for both the
recognition of the target sites and the binding of the target genes.
The SNP rs3746444 was not among the 2 267 487 SNPs analyzed
in our large BD meta-analysis.6 However, rs3746444 achieved a
nominally signiﬁcant P-value of 0.0023 (risk allele: rs3746444-G) in
a combined analysis of the seven MooDS samples (2266 patients
and 5028 controls),6 which excluded the PGC data set.3
Furthermore, the allele rs3746444-G has been associated with
hallucinations and lack of motivation in schizophrenia patients.50
This suggests that this SNP may confer susceptibility to BD by
inﬂuencing depressive and psychotic endophenotypes. However,
it may only partly explain the association signal at this locus.
Our target gene analysis revealed that miR-499 had four
signiﬁcant target genes, including the previously reported
genome-wide signiﬁcant risk gene for psychiatric disorders
CACNB2.51
Brain-expressed target genes of miR-499-5p exhibited an
enrichment in biological processes related to cerebral develop-
ment, which might however, at least partly, reﬂect the fact that
our pathway analysis was restricted to brain-expressed genes. In
addition, our pathway analysis indicates a potential role of
miR-499 in the regulation of the actin cytoskeleton. Interestingly,
this pathway has been identiﬁed in a previous investigation of
differentially and concordantly expressed genes enriched in
association signals for schizophrenia and BD.52 Substantial
research evidence suggests that the rearrangement of the
cytoskeleton is crucial for neuronal cell migration and maturation,
neurite outgrowth and maintenance of synaptic density and
plasticity.53–56 These combined data suggest that miR-499 is an
interesting candidate for BD pathogenesis.
The miRNA miR-708 is located in the ﬁrst intron of ODZ4 (odd
Oz/ten-m homolog 4, TENM4), which has been reported as a
genome-wide signiﬁcant susceptibility gene for BD.3
A recent study of postpartum psychosis—a disorder that often
heralds the incipient onset of BD57—suggested differential
expression of miR-708 in the monocytes of affected patients
compared with controls.58 In another study, Xu et al.59 demon-
strated an altered expression proﬁle for miR-708 in mouse
hippocampal neurons and showed that this was mediated by
oxidative stress. Another recent study found that miR-708
regulated the expression of neuronatin, which is a membrane
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Figure 2. Regional association plots of miR-499, miR-708 and miR-1908. Regional association results for the three most promising associated
microRNAs miR-499 (a), miR-708 (b) and miR-1908 (c), and their ± 500-kb ﬂanking regions were plotted using LocusZoom (Pruim et al.36). The
plot of miR-1908 (c) includes miR-611, which is also localized at the depicted chromosomal locus.
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protein in the endoplasmic reticulum. Interestingly, the
neuronatin-mediated regulation of intracellular Ca2+ levels has
been implicated in cell migration and neural induction within
embryonic stem cells.60
Our target gene analysis revealed that miR-708 had two
signiﬁcant target genes. These include CREB1 that has previously
been identiﬁed as a susceptibility gene for major depressive
disorder.61–63 In addition, CREB1 was found to be associated with
BD in a recent study of large-scale BD samples64 that included
8403 patients and 11 588 controls of our BD GWAS.6 However, the
present pathway analysis provided no strong evidence for an
enrichment of biological processes of relevance to psychiatric
disorder.
MiR-1908 is located in the ﬁrst intron of the fatty acid desaturase
1 (FADS1) gene on chromosome 11. To date, few published studies
have investigated the function of miR-1908. One recent study
implicated miR-1908 as a cancer biomarker.65 A further study
found that miR-1908 belonged to a miRNA cluster that down-
regulates the MARK1 signaling pathway, thus altering cell
proliferation and differentiation.66
Pathway analysis results for miR-1908 indicate a potential role of
the miRNA-regulated target gene network in key neuronal
processes (GO subcategories: neuron projection and nervous
system development). As these pathways showed the strongest
enrichment, further research into miR-1908 and its regulated
network appears to be warranted.
Although initial efforts have been made to elucidate the
regulation of miRNA expression,67 the manner in which miRNA
expression and processing are regulated remains largely
unknown. Given that pri-miRNAs have a length of 100–1000 -
bp,16 the present study investigated common variants at the
miRNA loci and ± 20 kb ﬂanking sequences in order to capture
possible regulatory regions. However, further analyses of the
regulation of miRNA expression by common variants are required
to determine whether, and how, the presently described
association signals inﬂuence the expression levels and function
of the implicated miRNAs. The present approach did not allow
investigation of SNPs with trans-expression quantitative trait loci
(eQTL) effects on miRNAs. As recent studies suggest that ~ 50% of
the identiﬁed miRNA eQTLs are trans-eQTLs,68 investigations into
the association between miRNA trans-eQTLs and BD are indicated.
The results of the functional analyses of miR-499 and miR-708 in
rat hippocampal neurons revealed no major contribution of these
miRNAs to the morphogenesis of dendritic spines, which
represent the major sites of synaptic contact. However, only the
results for miR-499 can be considered robust, as the miR-708
expression construct did not increase miR-708 in primary neurons
effectively. Alternative strategies for miR-708 expression, together
Table 2. Target gene and pathway analysis for miR-499, miR-708 and miR-1908
MicroRNA No. of brain-expressed target
genes
No. of brain-expressed target
genes, Po0.05
P enrichment No. of signiﬁcant targets
(corr)
No. of signiﬁcant
pathways
miR-499-5p 286 59 0.7172 4 12
miR-708-5p 174 37 0.9265 2 1
miR-1908-5p 56 17 0.1422 1 5
Abbreviations: No. of signiﬁcant pathways, number of signiﬁcant pathways at P≤ 0.05; No. of signiﬁcant targets (corr), number of signiﬁcant target genes after
Bonferroni correction for multiple testing; P enrichment, P-value of the enrichment analysis (Χ2-test). Results of the target gene analysis for the three brain-
expressed microRNAs miR-499, miR-708 and miR-1908 that were associated with bipolar disorder after correction for multiple testing.
Figure 3. Effect of the overexpression of miR-499 and miR-708 on dendritic spine size and density in primary rat hippocampal neurons. DIV14
primary hippocampal neurons were transfected with: (i) empty pmirGLO (250 ng) or (ii) pmirGLO (250 ng) containing pri-miR-499 or pri-miR-708
in the 3’-untranslated repeat of the Fireﬂy luciferase gene and green ﬂuorescent protein (GFP). The transfected neurons were then cultured
until DIV19 and ﬁxed for ﬂuorescence microscopy. (a) Representative images for cells transfected with the indicated pmirGLO constructs or
GFP only. A three-dimensional reconstruction was made from seven 45-μm stacks; scale bars, 5 μm. (b) Spine volume quantiﬁcation of
hippocampal neurons transfected with the indicated pmirGLO constructs. Values are represented as means± s.d. (n= 3; 24 neurons per
condition with a 200–250 spine count per cell). (c) Spine density of hippocampal neurons transfected with the indicated pmirGLO constructs.
Values are represented as means± s.d. per 10 μm dendritic length (n= 3; 24 neurons per condition). Data are presented as the mean of three
independent transfections normalized to the empty pmirGLO condition± s.d.
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with miR-499/708 loss-of-function approaches, must be tested
before deﬁnite conclusions regarding the role of these miRNAs in
dendritic spine morphogenesis can be drawn. Moreover, to obtain
more comprehensive insights into the potential effects of these
miRNAs on synaptic function, future experiments should be
complemented by immunocytochemistry analyses of synaptic
marker proteins and electrophysiological recordings. Beyond a
potential involvement in dendritic spine morphogenesis, these
miRNAs could also regulate other aspects of neuronal morphol-
ogy, such as dendrite arborization or axon growth, which could be
tested in future studies.
CONCLUSION
The results of the present miRNA and target gene analyses
suggest that the brain-expressed miRNAs miR-499, miR-708 and
miR-1908 may contribute to the development of BD. Further
research is warranted to elucidate the involvement of these
miRNAs and their downstream pathways in BD.
CONFLICT OF INTEREST
The authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
We are grateful to all of the patients and control subjects who contributed to this
study. The study was supported by the German Federal Ministry of Education and
Research (BMBF) through the Integrated Network IntegraMent (Integrated Under-
standing of Causes and Mechanisms in Mental Disorders), under the auspices of the
e:Med Programme (grant 01ZX1314A to MMN and SC, grant 01ZX1314G to MR, grant
01ZX1314J to BMM), and through e:AtheroSysMed (Systems medicine of myocardial
infarction and stroke, grant 01ZX1313B to BMM). MMN is a member of the DFG-
funded Excellence-Cluster ImmunoSensation. MMN also received support from the
Alfried Krupp von Bohlen und Halbach-Stiftung. The study was supported by the
German Research Foundation (DFG; grant FOR2107; RI908/11-1 to MR; SCHR1136/3-1
to GS; NO246/10-1 to MMN). MG-S received the grant no. 89/2012 from UEFISCDI,
Romania. Canadian patients were genotyped within the ConLiGen project (www.
ConLiGen.org), with the support of a grant from the Deutsche Forschungsge-
meinschaft to MR, MB and TGS (RI 908/7-1). Controls for Germany II were drawn from
the Heinz Nixdorf Recall Study (HNR) cohort, which was established with the support
of the Heinz Nixdorf Foundation. Recruitment of the Australian sample was
supported by an Australian NHMRC program grant (number 1037196). The
recruitment of the Canadian patients was supported by a grant from the Canadian
Institutes of Health Research #64410 to MA. The study also used data generated by
the GABRIEL consortium (controls for the sample Russia). Funding for the generation
of these data was provided by the European Commission as part of GABRIEL contract
number 018996 under the Integrated Program LSH-2004-1.2.5-1. Post-genomic
approaches to understand the molecular basis of asthma aiming at a preventive or
therapeutic control and the Wellcome Trust under award 084703. Canadian controls
were drawn from the French Canadian study (SLSJ), which was supported in part by
the Canada Research Chair Environment and genetics of respiratory diseases and
allergy, the Canadian Institutes of Health Research (Operating grant No. MOP-13506)
and the Quebec Respiratory Network of the Fonds de recherche en Santé du Québec
(FRQS). Polish controls were recruited by the International Agency for Research on
Cancer (IARC)/Centre National de Genotypage (CNG) GWAS Initiative. We thank the
Bipolar Disorder Working Group of the PGC (PGC-BD) for providing access to the
relevant data.
REFERENCES
1 Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013; 381: 1654–1662.
2 Nothen MM, Nieratschker V, Cichon S, Rietschel M. New ﬁndings in the genetics of
major psychoses. Dialogues Clin Neurosci 2010; 12: 85–93.
3 Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale gen-
ome-wide association analysis of bipolar disorder identiﬁes a new susceptibility
locus near ODZ4. Nat Genet 2011; 43: 977–983.
4 Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B et al. A genome-
wide association study implicates diacylglycerol kinase eta (DGKH) and several
other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13: 197–207.
5 Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al.
Collaborative genome-wide association analysis supports a role for ANK3 and
CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056–1058.
6 Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J et al.
Genome-wide association study reveals two new risk loci for bipolar disorder. Nat
Commun 2014; 5: 3339.
7 Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders:
the emerging picture and its implications. Nat Rev Genet 2012; 13: 537–551.
8 Nurnberger JI Jr., Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I et al. Identi-
ﬁcation of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014;
71: 657–664.
9 Fineberg SK, Kosik KS, Davidson BL. MicroRNAs potentiate neural development.
Neuron 2009; 64: 303–309.
10 Schratt G. MicroRNAs at the synapse. Nat Rev Neurosci 2009; 10: 842–849.
11 Forstner AJ, Degenhardt F, Schratt G, Nöthen MM. MicroRNAs as the cause of
schizophrenia in 22q11.2 deletion carriers, and possible implications for idio-
pathic disease: a mini-review. Front Mol Neurosci 2013; 6: 47.
12 Xu B, Karayiorgou M, Gogos JA. MicroRNAs in psychiatric and neurodevelop-
mental disorders. Brain Res 2010; 1338: 78–88.
13 Kim AH, Reimers M, Maher B, Williamson V, McMichael O, McClay JL et al.
MicroRNA expression proﬁling in the prefrontal cortex of individuals affected with
schizophrenia and bipolar disorders. Schizophr Res 2010; 124: 183–191.
14 Moreau MP, Bruse SE, David-Rus R, Buyske S, Brzustowicz LM. Altered microRNA
expression proﬁles in postmortem brain samples from individuals with schizo-
phrenia and bipolar disorder. Biol Psychiatry 2011; 69: 188–193.
15 Godnic I, Zorc M, Jevsinek Skok D, Calin GA, Horvat S, Dovc P et al. Genome-wide
and species-wide in silico screening for intragenic MicroRNAs in human, mouse
and chicken. PLoS One 2013; 8: e65165.
16 Mafﬁoletti E, Tardito D, Gennarelli M, Bocchio-Chiavetto L. Micro spies from the
brain to the periphery: new clues from studies on microRNAs in neuropsychiatric
disorders. Front Cell Neurosci 2014; 8: 75.
17 Rodriguez A, Grifﬁths-Jones S, Ashurst JL, Bradley A. Identiﬁcation of mammalian
microRNA host genes and transcription units. Genome Res 2004; 14: 1902–1910.
18 Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in
primary microRNA processing. Genes Dev 2004; 18: 3016–3027.
19 Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al. The nuclear RNase III Drosha initiates
microRNA processing. Nature 2003; 425: 415–419.
20 Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogen-
esis, function and decay. Nat Rev Genet 2010; 11: 597–610.
21 Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples
microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123:
631–640.
22 He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat
Rev Genet 2004; 5: 522–531.
23 Meola N, Gennarino VA, Banﬁ S. microRNAs and genetic diseases. Pathogenetics
2009; 2: 7.
24 Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;
116: 281–297.
25 Didiano D, Hobert O. Molecular architecture of a miRNA-regulated 3' UTR. RNA
2008; 14: 1297–1317.
26 Sathyan P, Golden HB, Miranda RC. Competing interactions between micro-RNAs
determine neural progenitor survival and proliferation after ethanol exposure:
evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J
Neurosci 2007; 27: 8546–8557.
27 Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening
and balancing of Nodal agonist and antagonist by miR-430. Science 2007; 318:
271–274.
28 Johnston RJ, Hobert O. A microRNA controlling left/right neuronal asymmetry in
Caenorhabditis elegans. Nature 2003; 426: 845–849.
29 Geeleher P, Huang SR, Gamazon ER, Golden A, Seoighe C. The regulatory effect of
miRNAs is a heritable genetic trait in humans. BMC Genomics 2012; 13: 383.
30 Forstner AJ, Basmanav FB, Mattheisen M, Bohmer AC, Hollegaard MV, Janson E
et al. Investigation of the involvement of MIR185 and its target genes in the
development of schizophrenia. J Psychiatry Neurosci 2014; 39: 386–396.
31 Lopez JP, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B et al. miR-1202 is a
primate-speciﬁc and brain-enriched microRNA involved in major depression and
antidepressant treatment. Nat Med 2014; 20: 764–768.
32 Strazisar M, Cammaerts S, van der Ven K, Forero DA, Lenaerts AS, Nordin A et al.
MIR137 variants identiﬁed in psychiatric patients affect synaptogenesis and
neuronal transmission gene sets. Mol Psychiatry 2015; 20: 472-481.
33 Wang Z, Zhang C, Huang J, Yuan C, Hong W, Chen J et al. MiRNA-206 and BDNF
genes interacted in bipolar I disorder. J Affect Disord 2014; 162: 116–119.
34 Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatile
gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87:
139–145.
microRNAs in bipolar disorder
AJ Forstner et al
7
Translational Psychiatry (2015), 1 – 8
35 Kozomara A, Grifﬁths-Jones S. miRBase: annotating high conﬁdence microRNAs
using deep sequencing data. Nucleic Acids Res 2014; 42: D68–D73.
36 Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP et al. LocusZoom:
regional visualization of genome-wide association scan results. Bioinformatics
2010; 26: 2336–2337.
37 Ziats MN, Rennert OM. Identiﬁcation of differentially expressed microRNAs across
the developing human brain. Mol Psychiatry 2014; 19: 848–852.
38 Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M et al.
A functional screen implicates microRNA-138-dependent regulation of the
depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol
2009; 11: 705–716.
39 Hackenberg M, Rodriguez-Ezpeleta N, Aransay AM. miRanalyzer: an update on the
detection and analysis of microRNAs in high-throughput sequencing experi-
ments. Nucleic Acids Res 2011; 39: W132–W138.
40 Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often ﬂanked by adeno-
sines, indicates that thousands of human genes are microRNA targets. Cell 2005;
120: 15–20.
41 Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA et al. An
anatomically comprehensive atlas of the adult human brain transcriptome. Nature
2012; 489: 391–399.
42 Baskerville S, Bartel DP. Microarray proﬁling of microRNAs reveals frequent
coexpression with neighboring miRNAs and host genes. RNA 2005; 11: 241–247.
43 Lutter D, Marr C, Krumsiek J, Lang EW, Theis FJ. Intronic microRNAs support their
host genes by mediating synergistic and antagonistic regulatory effects. BMC
Genomics 2010; 11: 224.
44 Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical
association of ncRNA with introns. Nucleic Acids Res 2011; 39: 2357–2366.
45 Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E et al.
Replication of bipolar disorder susceptibility alleles and identiﬁcation of two
novel genome-wide signiﬁcant associations in a new bipolar disorder case-
control sample. Mol Psychiatry 2013; 18: 1302–1307.
46 Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP et al. miR-499 regulates mito-
chondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat
Med 2011; 17: 71–78.
47 Smalheiser NR, Lugli G, Zhang H, Rizavi H, Cook EH, Dwivedi Y. Expression of
microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar
disorder and depressed subjects. PLoS One 2014; 9: e86469.
48 Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J et al. Differential
expression of exosomal microRNAs in prefrontal cortices of schizophrenia and
bipolar disorder patients. PLoS One 2013; 8: e48814.
49 Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G et al. Genome-wide identiﬁ-
cation of SNPs in microRNA genes and the SNP effects on microRNA target
binding and biogenesis. Hum Mutat 2012; 33: 254–263.
50 Zou M, Li D, Lv R, Zhou Y, Wang T, Liu J et al. Association between two single
nucleotide polymorphisms at corresponding microRNA and schizophrenia in a
Chinese population. Mol Biol Rep 2012; 39: 3385–3391.
51 Cross-Disorder Group of the Psychiatric Genomics Consortium. Identiﬁcation of
risk loci with shared effects on ﬁve major psychiatric disorders: a genome-wide
analysis. Lancet 2013; 381: 1371–1379.
52 Zhao Z, Xu J, Chen J, Kim S, Reimers M, Bacanu SA et al. Transcriptome
sequencing and genome-wide association analyses reveal lysosomal function
and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol
Psychiatry 2015; 20: 563-572.
53 Auer M, Hausott B, Klimaschewski L. Rho GTPases as regulators of morphological
neuroplasticity. Ann Anat 2011; 193: 259–266.
54 Bellenchi GC, Gurniak CB, Perlas E, Middei S, Ammassari-Teule M, Witke W.
N-coﬁlin is associated with neuronal migration disorders and cell cycle control in
the cerebral cortex. Genes Dev 2007; 21: 2347–2357.
55 de Curtis I. Functions of Rac GTPases during neuronal development. Dev Neurosci
2008; 30: 47–58.
56 Kreis P, Barnier JV. PAK signalling in neuronal physiology. Cell Signal 2009; 21:
384–393.
57 Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results
of a family study. Am J Psychiatry 2001; 158: 913–917.
58 Weigelt K, Bergink V, Burgerhout KM, Pescatori M, Wijkhuijs A, Drexhage HA.
Down-regulation of inﬂammation-protective microRNAs 146a and 212 in mono-
cytes of patients with postpartum psychosis. Brain Behav Immun 2013; 29:
147–155.
59 Xu S, Zhang R, Niu J, Cui D, Xie B, Zhang B et al. Oxidative stress mediated-
alterations of the microRNA expression proﬁle in mouse hippocampal neurons.
Int J Mol Sci 2012; 13: 16945–16960.
60 Ryu S, McDonnell K, Choi H, Gao D, Hahn M, Joshi N et al. Suppression of
miRNA-708 by polycomb group promotes metastases by calcium-induced cell
migration. Cancer Cell 2013; 23: 63–76.
61 Carlezon WA Jr., Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci
2005; 28: 436–445.
62 Maher BS, Hughes HB 3rd, Zubenko WN, Zubenko GS. Genetic linkage of region
containing the CREB1 gene to depressive disorders in families with recurrent,
early-onset, major depression: a re-analysis and conﬁrmation of sex-
speciﬁc effect. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 10–16.
63 Wallace TL, Stellitano KE, Neve RL, Duman RS. Effects of cyclic adenosine
monophosphate response element binding protein overexpression in the baso-
lateral amygdala on behavioral models of depression and anxiety. Biol Psychiatry
2004; 56: 151–160.
64 Li M, Luo XJ, Rietschel M, Lewis CM, Mattheisen M, Muller-Myhsok B et al. Allelic
differences between Europeans and Chinese for CREB1 SNPs and their implica-
tions in gene expression regulation, hippocampal structure and function, and
bipolar disorder susceptibility. Mol Psychiatry 2014; 19: 452–461.
65 Rawlings-Goss RA, Campbell MC, Tishkoff SA. Global population-speciﬁc variation
in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics
2014; 7: 53.
66 Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS, Zhang XS et al. Tumor-derived exosomes
promote tumor progression and T-cell dysfunction through the regulation of
enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget
2014; 5: 5439–5452.
67 Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, Cox NJ et al. Genetic architecture
of microRNA expression: implications for the transcriptome and complex traits.
Am J Hum Genet 2012; 90: 1046–1063.
68 Borel C, Deutsch S, Letourneau A, Migliavacca E, Montgomery SB, Dimas AS et al.
Identiﬁcation of cis- and trans-regulatory variation modulating microRNA
expression levels in human ﬁbroblasts. Genome Res 2011; 21: 68–73.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)
microRNAs in bipolar disorder
AJ Forstner et al
8
Translational Psychiatry (2015), 1 – 8
